23.5 C
New York
Thursday, July 3, 2025

Tag: European Union

newssourcecompanyFORcontentinformation1marketbusiness

Transaction in Own Shares

LEI: 213800NNT42FFIZB1T09 
3 July 2025

Transaction in Own Shares

Transaction in Own Shares

Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma

Lynozyfic is a bispecific antibody directing T cells to kill multiple myeloma cancer cells; multiple myeloma is the second most common blood cancer 

Identiv Partners with Narravero to Accelerate Digital Product Passport Adoption and Compliance

Companies to Commercialize Integrated Solution for DPP Deployments Ahead of Forthcoming European Union Regulations SANTA ANA, Calif., July 2, 2025 /PRNewswire/ -- Identiv, Inc. (NASDAQ:...

BBVA Deepens Partnership with Google Cloud to Innovate with AI

BBVA is taking a strategic step in its digital transformation by expanding its long-standing collaboration with Google Cloud through the deployment of Google...

PMI in India Reiterated its Commitment to Break the Illicit Tobacco Trade Trinity Through Concerted Efforts and Government Collaborations on World Anti-Counterfeiting Day

Stopping illegal tobacco trade could help contain the informal tobacco economy, secure product integrity, and ensure a better livelihood for tobacco farmersThe move would...

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch

Transaction in Own Shares

Transaction in Own Shares

Cold Jet Unlocks Significant New Revenue Opportunities for RNG Biomethane Sites Through Advanced Carbon Capture and Dry Ice Production

Cold Jet enables RNG biomethane sites to turn CO2 emissions into high-value dry ice, unlocking significant new revenue streams.

Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera® (zanidatamab) for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

– Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b trial – DUBLIN, July 1, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...

Automotive Tire Pressure Monitoring System Market Set to Hit USD 8.94 Billion in 2024, Accelerating Ahead with a Robust 12.91% CAGR Through 2032 |...

Automotive Tire Pressure Monitoring System Market, By Product Type (Direct and Indirect), By Vehicle Type, By Component, By Sales Channel, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 
Automotive Tire Pressure Monitoring System Market, By Product Type (Direct and Indirect), By Vehicle Type, By Component, By Sales Channel, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Trump’s Tariff Tantrum: Trade Deals Take a Nap

As the globe spins toward yet another round of economic brinkmanship, America's trading partners scramble to ink deals with the U.S., a move akin...

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

EINDHOVEN, the Netherlands, July 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announced the submission of two major regulatory applications for its ARC-EX System. The Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) seeking clearance to expand its indication for home use. In parallel, ONWARD has filed an application with the notified body for CE Mark certification in accordance with the European Union Medical Device Regulation (MDR) to enable commercialization of the ARC-EX System in the EU. Completed in June, these submissions represent significant milestones as the Company advances its mission to bring breakthrough therapies to people with SCI around the world.

Europe Single-use Bioreactors Market to Reach $3.34 Billion by 2032, Growing at a CAGR of 15.3% from 2025, Says Meticulous Research®

Market Growth Driven by Rapid Disposable Technology Adoption, Expanding Biopharmaceutical Sector, and Government Support for Bioproduction REDDING, Calif., June 30, 2025 /PRNewswire/ --According to a...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEuropean Union

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers